EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs

Paula Wróblewska-Łuczka iD, Agnieszka Góralczyk iD, Jarogniew J Łuszczki iD

Cells · 09.06.2023 · 12 (12) · 1593

DOI: 10.3390/cells12121593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 09.06.2023. Verfasst von Paula Wróblewska-Łuczka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Medicine, Medical University of Lublin, ul. Jaczewskiego 8b, 20-090 Lublin, Poland. Hauptthemen laut MEDLINE: Cytostatic Agents, Melanoma. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1) The treatment of metastatic or drug-resistant melanoma is still a significant therapeutic problem. The aim of this study was to evaluate the anticancer potential of daphnetin (7,8-dihydroxycoumarin) and its combinations with five different cytostatic drugs (mitoxantrone, docetaxel, vemurafenib, epirubicin and cisplatin). (2) The viability, proliferation and cytotoxicity of daphnetin against four human malignant melanoma cell lines were evaluated. The interactions were assessed using isobolographic analysis for the combinations of daphnetin with each of the five cytostatic drugs. (3) Daphnetin showed anticancer activity against malignant melanoma, with IC50 values ranging from 40.48 ± 10.90 µM to 183.97 ± 18.82 µM, depending on the cell line. The combination of daphnetin with either vemurafenib or epirubicin showed an antagonistic interaction. Moreover, additive interactions were observed for the combinations of daphnetin with cisplatin and docetaxel. The most desirable synergistic interactions for human melanoma metastatic cell lines were observed for the combination of daphnetin with mitoxantrone. (4) The obtained results suggest that daphnetin should not be combined with vemurafenib or epirubicin in the treatment of malignant melanoma due to the abolition of their anticancer effects. The combination of daphnetin with mitoxantrone is beneficial in the treatment of metastatic melanoma due to their synergistic interaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytostatic AgentsMelanomaHumansVemurafenibDocetaxelCisplatinMitoxantroneEpirubicinCoumarinsCutaneous Malignant MelanomaUmbelliferones

Stichwörter der Autor:innen

chemotherapeuticscoumarinsdaphnetinisobolographic analysismelanoma

Substanzen

VemurafenibCytostatic AgentsDocetaxelCisplatinMitoxantroneEpirubicinCoumarinsdaphnetinUmbelliferones

Autor:innen und Institutionen

  • Department of Occupational Medicine, Medical University of Lublin, ul. Jaczewskiego 8b, 20-090 Lublin, Poland.

ORCID-Profile: Paula Wróblewska-Łuczka, Agnieszka Góralczyk, Jarogniew J Łuszczki

Förderung

  • Medical University of Lublin, Poland

Zitieren

APA

Wróblewska-Łuczka, P., Góralczyk, A., & Łuszczki, J. J. (2023). Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs. Cells, 12(12), 1593. https://doi.org/10.3390/cells12121593

Vancouver

Wróblewska-Łuczka P, Góralczyk A, Łuszczki JJ. Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs. Cells. 2023;12(12):1593. doi:10.3390/cells12121593

BibTeX
@article{Wrblewskauczka2023,
  author = {Wróblewska-Łuczka, Paula and Góralczyk, Agnieszka and Łuszczki, Jarogniew J},
  title = {Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {12},
  pages = {1593},
  doi = {10.3390/cells12121593}
}
Kostenlos starten →